Publications by authors named "Katrin Marie Sjoquist"
AGITG MONARCC: A Randomized Phase 2 Study of Panitumumab Monotherapy and Panitumumab Plus 5-Fluorouracil as First-Line Therapy for Older Patients With RAS and BRAF Wild Type Metastatic Colorectal Cancer. A Study by the Australasian Gastro-Intestinal Trials Group (AGITG).
Clin Colorectal Cancer
December 2024
Background: Panitumumab (pan) plus chemotherapy is a preferred first-line therapy for unresectable RAS and BRAF wild type metastatic colorectal cancer (mCRC). Older patients may not be suitable for combination regimens. We investigated 2 lower intensity pan-containing regimens.
View Article and Find Full Text PDFArticle Synopsis
- Gemcitabine/cisplatin is the usual treatment for advanced biliary tract cancer (aBTC), but scientists want to find better options.
- NUC-1031 is a new drug that might work better and help patients more than the standard treatment.
- A new study called NuTide:121 is testing NUC-1031 with cisplatin on 828 patients to see if it helps them live longer and feel better compared to the old treatment.